The CCC's Advisory Board was restructured in the fall of 2006 to create a smaller group of external stakeholders to advise the Centre. The new Advisory Board consists of members who provide a balance of high-level, strategic perspectives from across the Canadian healthcare landscape. Members come from various sectors and include clinician, research, policy and consumer representatives. These members have the capacity to strengthen the development of Cochrane activities, linkages and funding stability in Canada with their strategic advice and strong capacity for an advocacy role.
The previous Advisory Board members, consisting of a total of 47 Canadian group, partner and regional site representatives, still have a role of providing advice and support to the Centre by serving as a stakeholder group. They continue to provide input into strategic direction and implementation by participating in working groups and committees.
Advisory Board
| Name | Position |
| Krista Connell (Chair) | Chief Executive Officer; Nova Scotia Health Research Foundation Halifax, Nova Scotia |
| Timothy Caulfield | Canadian Research Chair in Health Law and Policy Professor, Faculty of Law and School of Public Health, Health Law Institute, University of Alberta Edmonton, Alberta |
| Heather Davidson | Assistant Deputy Minister, B.C. Health Planning and Innovation Division, Ministry of Health Victoria, British Columbia |
| Jean Légaré | Patient Partner in the Canadian Arthritis Network Québec City, Québec |
| Stuart MacLeod | Senior Clinician Scientist, Child and Family Research Institute (CFRI) Professor, Division of Administration, Department of Pediatrics, University of British Columbia Vice President, Academic Liaison and Research Coordinator, Provincial Health Services Authority Vancouver, British Columbia |
| François Rousseau | Professeur (médecin) Unité de recherche en génétique humaine et moléculaire Université Laval & CHUQ Université Laval Québec City, Québec |
